HS Code 30.03 – Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two or more constituents mixed together for therapeutic or prophylactic use not in measured doses or in forms or packings for retail sale

HS code 3003 is a 4-digit heading in the Harmonized System that covers: Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two or more constituents mixed together for therapeutic or prophylactic use not in measured doses or in forms or packings for retail sale. Heading 3003 covers "Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two or more constituents mixed together for therapeutic or prophylactic use not in measured doses or in forms or packings for retail sale." This is a crucial classification for intermediate pharmaceutical products, specifically bulk medicaments. It addresses formulations that combine two or more active or inactive constituents intended for therapeutic or prophylactic purposes, but which are not yet prepared in precise, measured doses or packaged for direct retail to consumers. The scope is defined by the mixture of constituents and the absence of retail-ready presentation. It clearly distinguishes these bulk preparations from single active pharmaceutical ingredients (APIs) in Chapter 29 and from finished, dose-form medicaments in 3004. Key examples include bulk solutions, suspensions, or powders that require further processing (e.g., bottling, tableting, encapsulation) before reaching the end-user. This heading is vital for trade compliance as it accurately reflects an intermediate stage in drug manufacturing, impacting duty rates, regulatory approvals, and supply chain management. Historically, this category has supported the global pharmaceutical industry's move towards specialized manufacturing and contract processing. It is intrinsically linked to the broader Chapter 30, which encompasses a wide range of pharmaceutical goods, providing a distinct classification for semi-finished drug products within Section VI.

Bulk cough syrup concentrate (active ingredients + excipients), Bulk oral suspension base, Unmixed pharmaceutical powders for compounding, Bulk injectable solutions (not yet in vials), Ophthalmic solution concentrates, Dermatological cream bases (API + base), Bulk veterinary drug mixtures (unmeasured), Medicated feed premixes (therapeutic, unmeasured), Bulk antibiotic solutions for further processing, Bulk vitamin mixtures for pharmaceutical use, Bulk antacid suspensions, Bulk pain relief formulations, Bulk laxative preparations, Bulk anti-inflammatory gels, Bulk antiseptic solutions, Bulk hormonal preparations (unmeasured), Bulk antifungal creams, Bulk antihistamine syrups, Bulk antipyretic suspensions, Bulk antiviral solutions, Bulk cardiovascular drug mixtures, Bulk gastrointestinal preparations, Bulk neurological drug formulations, Bulk dermatological lotions, Bulk respiratory drug solutions

The most common misclassification for 3003 is confusing it with 3004 (medicaments in measured doses or retail packings). The critical distinction is the *form and packing*: 3003 products are not in measured doses or ready for retail. Another error is classifying single active ingredients (even if mixed with a carrier) here, which typically belong to Chapter 29. Also, preparations for diagnostic use might fall under 3002 or 3822. The key is the requirement of 'two or more constituents mixed together' and the absence of a retail-ready, measured dose format.

In 2025, the top exporters of HS code 3003 in UN Comtrade data were Ireland ($7.7B, 35% of world exports), Portugal ($3.6B) and the United States ($1.2B). World exports came to about $22.2B, adding countries' reported figures and partner-based estimates for those that did not report (UN Comtrade data). Countries that did not report 2025 data are estimated from partner records, which can understate them.

In 2025, the top importers of HS code 3003 in UN Comtrade data were Belgium ($4.8B, 23% of world imports), Saudi Arabia ($2.9B) and the United States ($2.5B). World imports came to about $20.8B, adding countries' reported figures and partner-based estimates for those that did not report (UN Comtrade data). Countries that did not report 2025 data are estimated from partner records, which can understate them.

HS code 3003 is a 4-digit heading under Chapter 30 of the Harmonized System. The first 2 digits (30) identify the chapter, and digits 3-4 (03) specify the heading. This code contains multiple 6-digit subheadings for precise product classification.